Actividades
Recursos sobre trasplantes
Trasplante pulmonar: Artículos interesantes

Baum C, Reichenspurner H, Deuse T. Bortezomib rescue therapy in a patient with recurrent antibody-mediated rejection after lung transplantation. Heart Lung Transplant 2013 Sep 13. pii: S1053-2498 (13) 01413-7.

Cypel M, Keshavjee S. Strategies for safe donor expansion: donor management, donations after cardiac death, ex-vivo lung perfusion. Curr Opin Organ Transplant 2013 Aug 29. [Epub ahead of print]

Eberlein M, Diehl E, Bolukbas S, Merlo CA, Reed RM. An oversized allograft is associated with improved survival after lung transplantation for idiopathic pulmonary arterial hypertension. J Heart Lung Transplant 2013 Jul.

Snell GI, Holmes M, Levvey BJ, Shipp A, Robertson C, Westall GP, Cohney S. Lessons and Insights From ABO-Incompatible Lung Transplantation. Am J Transplant 2013 May; 13 (5): 1350-3.

Bittle GJ, Sanchez PG, Kon ZN, Claire Watkins A, Rajagopal K, Pierson RN 3rd, Gammie JS, Griffith BP. The use of lung donors older than 55 years: A review of the United Network of Organ Sharing database. J Heart Lung Transplant 2013 May 9.

Roman MA, Nair S, Tsui S, Dunning J, Parmar JS. Ex Vivo Lung Perfusion: A Comprehensive Review of the Development and Exploration of Future Trends. Transplantation. 2013 May 20.

Magnusson J, Westin J, Andersson LM, Brittain-Long R, Riise GC. The impact of viral respiratory tract infections on long-term morbidity and mortality following lung transplantation: a retrospective cohort study using a multiplex PCR panel. Transplantation 2013 Jan 27; 95 (2): 383-8.

Extracorporeal membrane oxygenation as a bridge to lung transplantation and recovery

Exercise training after lung transplantation improves participation in daily activity: a randomized controlled trial

Fulminant hyperacute rejection after unilateral lung transplantation

Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation

Extracorporeal membrane oxygenation as a bridge to lung transplantation and recovery

Primary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indications

Lung transplant for interstitial lung disease: outcomes before and after implementation of the united network for organ sharing lung allocation scoring system

Lung size mismatch in bilateral lung transplantation is associated with allograft function and bronchiolitis obliterans syndrome

Clinical lung transplantation from uncontrolled non-heart-beating donors revisited

Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation

Fibrinolytic Treatment Improves the Quality of Lungs Retrieved From Non-Heart-Beating Donors

Regression of Pulmonary Lymphangioleiomyomatosis (PLAM)-associated Retroperitoneal Angiomyolipoma Post–Lung Transplantation With Rapamycin Treatment

Platelet activation in the postoperative period after lung transplantation

Survival After Lung Transplantation of Cystic Fibrosis Patients Infected with Burkholderia cepacia Complex 

Infections in Lung Allograft Recipients: Ganciclovir Era

Sleep-disordered Breathing Before and After Lung Transplantation

Rabbit Anti-thymocyte Globulin Induction Therapy Does Not Prolong Survival After Lung Transplantation

Non-acidic Supraesophageal Reflux Associated With Diffuse Alveolar Damage and Allograft Dysfunction After Lung Transplantation: A Case Report

Extracorporeal Membrane Oxygenation as a Bridge to Emergency Heart-Lung Transplantation in a Patient With Idiopathic Pulmonary Arterial Hypertension